spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  bunionectomy 

 HSMN NewsFeed - 25 Sep 2024
Heron Therapeutics Announces FDA Approval of the Prior Approval Supplement Application for ZYNRELEF(R) Vial Access Needle ("VAN")
Devices Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Mar 2022
Heron Therapeutics Announces Approval of ZYNRELEF(R) by Health Canada for the Management of Postoperative Pain
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 1 Jul 2021
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF(TM) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 13 May 2021
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF(TM) (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Dec 2018
FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2017
Recro Pharma Appoints Bryan Reasons to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2015
Heron Therapeutics Appoints Neil J. Clendeninn, M.D., Ph.D. as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2013
Pacira Pharmaceuticals, Inc. Announces Positive Interim Analysis of EXPAREL in Femoral Nerve Block for Total Knee Arthroplasty
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2010
QRxPharma Successfully Completes Pivotal Phase 3 Combination Rule Study for MoxDuo(R)IR in Patients with Post-Surgical Pain
Biopharmaceuticals Surgery
 HSMN NewsFeed - 17 Jun 2009
Xanodyne Receives Approval From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Liquid Filled Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2009
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2008
Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
Biopharmaceuticals Orthopaedic
 HSMN NewsFeed - 3 Sep 2008
Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 22 Jul 2008
Xanodyne Receives Approvable Letter From the U.S. Food and Drug Administration for ZIPSOR(TM) (diclofenac potassium) Capsules
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Jun 2008
Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
King Pharmaceuticals and Acura Pharmaceuticals Announce Completion of Patient Enrollment for Pivotal Phase III Clinical Trial Evaluating ACUROX(TM)
Biopharmaceuticals
 HSMN NewsFeed - 8 Apr 2008
Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
Biopharmaceuticals
 HSMN NewsFeed - 25 Mar 2008
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2008
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
Devices Surgery Pain Management
 HSMN NewsFeed - 31 Oct 2007
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 10 Oct 2007
Anesiva Defines Regulatory Pathway for Adlea with FDA
Biopharmaceuticals Surgery
 HSMN NewsFeed - 27 Sep 2007
MGI PHARMA Announces Submission of Aquavan(R) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Apr 2007
Innocoll Receives FDA Approval to Commence Phase 2 Clinical Development with its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery
 HSMN NewsFeed - 29 Mar 2007
Innocoll Files US and Irish Patent Applications for its CollaRx(R) BUPIVACAINE IMPLANT for the Management of Post-operative Pain
Devices Surgery
 HSMN NewsFeed - 20 Mar 2007
MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2007
XTL Biopharmaceuticals Announces the In-Licensing of Bicifadine - A Late-Stage Clinical Compound for the Treatment of Neuropathic Pain
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 8

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 8 additional stories matching:
bunionectomy
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.